180 related articles for article (PubMed ID: 25544117)
1. Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization.
Secco GG; Parisi R; Mirabella F; Rognoni A; Lupi A; De Luca G; Marino PN; Fattori R; Cremonesi A; Castriota F
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):21-4. PubMed ID: 25544117
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Angina: Where Are We?
Balla C; Pavasini R; Ferrari R
Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
[TBL] [Abstract][Full Text] [Related]
3. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
Rosano GMC; Vitale C; Volterrani M
Cardiovasc Drugs Ther; 2016 Aug; 30(4):393-398. PubMed ID: 27417323
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic management of chronic stable angina.
Dixit D; Kimborowicz K
JAAPA; 2015 Jun; 28(6):. PubMed ID: 25989429
[TBL] [Abstract][Full Text] [Related]
6. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis.
Belsey J; Savelieva I; Mugelli A; Camm AJ
Eur J Prev Cardiol; 2015 Jul; 22(7):837-48. PubMed ID: 24776376
[TBL] [Abstract][Full Text] [Related]
7. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
[TBL] [Abstract][Full Text] [Related]
9. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes.
Manolis A; Kallistratos M; Poulimenos L; Thomopoulos C
Am J Med Sci; 2024 Mar; 367(3):155-159. PubMed ID: 38072070
[TBL] [Abstract][Full Text] [Related]
10. Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.
Zarifis J; Grammatikou V; Kallistratos M; Katsivas A
Angiology; 2017 Jan; 68(1):10-18. PubMed ID: 26960667
[TBL] [Abstract][Full Text] [Related]
11. Stable angina pectoris: current medical treatment.
Siama K; Tousoulis D; Papageorgiou N; Siasos G; Tsiamis E; Bakogiannis C; Briasoulis A; Androulakis E; Tentolouris K; Stefanadis C
Curr Pharm Des; 2013; 19(9):1569-80. PubMed ID: 23016717
[TBL] [Abstract][Full Text] [Related]
12. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
13. Update on the medical treatment of stable angina.
Gayet JL; Paganelli F; Cohen-Solal A
Arch Cardiovasc Dis; 2011 Oct; 104(10):536-44. PubMed ID: 22044707
[TBL] [Abstract][Full Text] [Related]
14. Conventional and novel drug therapeutics to relief myocardial ischemia.
Dvir D; Battler A
Cardiovasc Drugs Ther; 2010 Aug; 24(4):319-23. PubMed ID: 20658184
[TBL] [Abstract][Full Text] [Related]
15. Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
Ambrosio G; Tamargo J; Grant PJ
Diab Vasc Dis Res; 2016 Mar; 13(2):98-112. PubMed ID: 26873904
[TBL] [Abstract][Full Text] [Related]
16. Stable angina pectoris.
Valgimigli M; Biscaglia S
Curr Atheroscler Rep; 2014 Jul; 16(7):422. PubMed ID: 24838374
[TBL] [Abstract][Full Text] [Related]
17. Anti-anginal drugs: Systematic review and clinical implications.
Pavasini R; Camici PG; Crea F; Danchin N; Fox K; Manolis AJ; Marzilli M; Rosano GMC; Lopez-Sendon JL; Pinto F; Balla C; Ferrari R
Int J Cardiol; 2019 May; 283():55-63. PubMed ID: 30538056
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.
Cacciapuoti F
Ther Adv Cardiovasc Dis; 2016 Apr; 10(2):98-102. PubMed ID: 26944071
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Trimetazidine Treatment in Patients with Stable Angina Pectoris of Various Durations: Results from the CHOICE-2 Study.
Glezer M;
Adv Ther; 2018 Jul; 35(7):1103-1113. PubMed ID: 29766461
[TBL] [Abstract][Full Text] [Related]
20. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Zhu H; Xu X; Fang X; Zheng J; Zhao Q; Chen T; Huang J
Clin Ther; 2019 Oct; 41(10):2137-2152.e12. PubMed ID: 31548105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]